HCV Protease Inhibitors in Clinical Practice

download HCV Protease Inhibitors in Clinical Practice

If you can't read please download the document

  • date post

    31-Dec-2015
  • Category

    Documents

  • view

    36
  • download

    6

Embed Size (px)

description

HCV Protease Inhibitors in Clinical Practice. Currently Approved HCV Agents: Telaprevir and Boceprevir. Patient Selection for HCV Triple Therapy. Telaprevir: Recommended Treatment Duration (Weeks). Telaprevir + PEG-IFN- α -2a + RBV for HCV Genotype 1. - PowerPoint PPT Presentation

Transcript of HCV Protease Inhibitors in Clinical Practice

HCV Protease Inhibitors in Clinical Practice

HCV Protease Inhibitors in Clinical Practice

Currently Approved HCV Agents: Telaprevir and Boceprevir

Patient Selection for HCV Triple Therapy

Telaprevir: Recommended Treatment Duration (Weeks)

Telaprevir + PEG-IFN--2a + RBV for HCV Genotype 1

Boceprevir: Recommended Treatment Duration (Weeks)

Boceprevir + PEG-IFN--2b + RBV for HCV Genotype 1

Select Predictors of SVR in Chronic HCV Genotype 1 Therapy

Selected Adverse Events

HCV Treatment-related Anemia

Preparing Patients for HCV Treatment

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)